From: Consumer input into research: the Australian Cancer Trials website
Data item | Options |
---|---|
Cancer stage | Early |
 | Locally recurrent or locally advanced |
 | Metastatic/Widespread |
 | Not applicable |
Treatment type (s) | Treatment: Hormones |
 | Treatment: Chemotherapy |
 | Treatment: Targeted therapies and biological therapies |
 | Treatment: Radiotherapy |
 | Treatment: Surgery |
 | Treatment: Other |
 | Antiemetics |
 | Complementary |
 | Palliative care |
 | Prevention/Screening |
 | Psychosocial (counselling/training/communication/education) |
 | Lifestyle |
 | Rehabilitation |
State (s) of recruitment | The Australian state (s) where the participants are being recruited |
Anticipated or actual recruitment end date | The anticipated or actual date the trial will stop recruiting patients |
Side effects | The known and possible side effect (s) for each trial arm from most to least common |
Cost to participants | Similar cost as usual care |
 | Less cost than usual care |
 | More cost than usual care |
Time commitments | Similar time commitment as usual care |
 | Less time commitment than usual care |
 | More time commitment than usual care |
Lay summary written by a medical writer | Format of summary: |
 |    • An initial sentence summarizing the trial purpose |
 |    • A section describing the patient eligibility under the heading "Who is it for?" |
 |    • A section entitled "Trial details" which describes the trial design, intervention(s) and comparator(s) and outcome measures of the trial |